Vanguard Group Portfolio holdings
The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.18B |
| 2 |
Medtronic
MDT
|
+$2.06B |
| 3 |
Microsoft
MSFT
|
+$1.61B |
| 4 |
Procter & Gamble
PG
|
+$1.47B |
| 5 |
UBS Group
UBS
|
+$1.01B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.42B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$2.34B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$930M |
| 4 |
Apple
AAPL
|
+$637M |
| 5 |
SWY
SAFEWAY INC
SWY
|
+$620M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.67% |
| 2 | Technology | 13.6% |
| 3 | Financials | 13.57% |
| 4 | Industrials | 10.71% |
| 5 | Consumer Discretionary | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATCO
3451
DELISTED
Atlas Corp.
ATCO
| $1.79M | ﹤0.01% |
98,279
+11,885
| +14% | +$217K |
|
3452
Savara
SVRA
$1.19B
| $1.79M | ﹤0.01% |
52,787
+4,466
| +9% | +$155K |
|
3453
Silicom
SILC
$239M
| $1.79M | ﹤0.01% |
+43,323
| New | +$1.81M |
|
3454
Evogene
EVGN
$8.29M
| $1.79M | ﹤0.01% |
+20,280
| New | +$1.89M |
|
3455
CEL-SCI Corp
CVM
$28.1M
| $1.78M | ﹤0.01% |
2,263
+163
| +8% | +$107K |
|
|
EMMS
3456
DELISTED
Emmis Communications Corp
EMMS
| $1.78M | ﹤0.01% |
237,761
+4,977
| +2% | +$36.9K |
|
|
VIAS
3457
DELISTED
VIASYSTEMS GROUP INC COM STK (DE)
VIAS
| $1.76M | ﹤0.01% |
100,484
-84
| -0.1% | -$1.43K |
|
3458
Vanguard FTSE All-World ex-US ETF
VEU
$67.8B
| $1.75M | ﹤0.01% |
36,007
+17,506
| +95% | +$842K |
|
|
LAND
3459
Gladstone Land Corp
LAND
$360M
| $1.75M | ﹤0.01% |
145,081
+36,387
| +33% | +$400K |
|
|
DWCH
3460
DELISTED
Datawatch Corp
DWCH
| $1.74M | ﹤0.01% |
256,368
+45,500
| +22% | +$297K |
|
3461
Gilat Satellite Networks
GILT
$852M
| $1.73M | ﹤0.01% |
+286,620
| New | +$1.43M |
|
3462
Hingham Institution for Saving
HIFS
$658M
| $1.73M | ﹤0.01% |
17,508
+816
| +5% | +$75.6K |
|
|
CBIO
3463
Crescent Biopharma
CBIO
$610M
| $1.73M | ﹤0.01% |
2,079
+33
| +2% | +$25.6K |
|
|
YUME
3464
DELISTED
YuMe, Inc.
YUME
| $1.73M | ﹤0.01% |
333,078
+30,048
| +10% | +$163K |
|
|
IMDZ
3465
DELISTED
Immune Design Corp.
IMDZ
| $1.71M | ﹤0.01% |
81,003
+20,823
| +35% | +$543K |
|
|
TST
3466
DELISTED
TheStreet, Inc.
TST
| $1.71M | ﹤0.01% |
94,919
+730
| +0.8% | +$14.8K |
|
|
WSTL
3467
DELISTED
Westell Technologies Inc
WSTL
| $1.69M | ﹤0.01% |
322,675
+23,800
| +8% | +$133K |
|
3468
US Global Investors
GROW
$38.5M
| $1.69M | ﹤0.01% |
528,615
+8,516
| +2% | +$26.9K |
|
|
FMD
3469
DELISTED
FIRST MARBLEHEAD CORP COM STK NEW (DE)
FMD
| $1.67M | ﹤0.01% |
268,418
+43,453
| +19% | +$253K |
|
|
FSBK
3470
DELISTED
First South Bancorp Inc/VA
FSBK
| $1.66M | ﹤0.01% |
205,790
| – | – |
|
|
KSPN
3471
DELISTED
Kaspien Holdings Inc. Common Stock
KSPN
| $1.64M | ﹤0.01% |
22,109
+5
| +0% | +$353 |
|
3472
Odyssey Marine Exploration
OMEX
$44M
| $1.63M | ﹤0.01% |
193,899
+1,870
| +1% | +$17.7K |
|
3473
Nuwellis
NUWE
$594K
| – | – |
0
| – | – |
|
3474
Lakeland Industries
LAKE
$117M
| $1.62M | ﹤0.01% |
181,193
+34,164
| +23% | +$318K |
|
|
OCRX
3475
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $1.62M | ﹤0.01% |
344,293
+54,809
| +19% | +$316K |
|
Similar funds
Vanguard Group's Q1 2015 Portfolio in Review
As of Q1 2015, Vanguard Group held 4,228 positions worth $1.47T, up 6.2% from $1.39T the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Vanguard Group deployed $66B of net new capital in Q1 2015, opening 181 new positions and adding to 3,456 existing holdings. Its largest new stake was UBS Group: 57,940,325 shares worth $1.09B.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Apple, an estimated $637M trimmed.
- Vanguard Group's largest Q1 2015 buy was UBS Group: 57,940,325 shares worth $1.09B.
- Vanguard Group added most to Allergan plc in Q1 2015, an estimated $2.18B increase.
- Vanguard Group's biggest Q1 2015 reduction was Apple, cutting an estimated $637M.
- Vanguard Group fully exited Allergan Inc in Q1 2015, selling an estimated $3.42B.
- Vanguard Group's ten largest holdings make up 12% of its $1.47T portfolio in Q1 2015.
- Vanguard Group opened 181 new positions and closed 75 in Q1 2015.
- Vanguard Group's portfolio value rose 6.2% quarter-over-quarter to $1.47T.
Based on Vanguard Group's 13F filing for Q1 2015, filed 14 May 2015.